Bioceltix

We develop innovative biopharmaceuticals based on stem cells.

Total raised

€2.5M

€2,500,000

Funding rounds

Investors

distinct backers

Active since

2019-09

latest 2024-01

Funding by year

EUR raised per year

Medium confidence

Raise-next likelihood22

base rate 30% for Other

Exit likelihood13

base rate 12% (2+ rounds)

Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.

2 rounds

Date	Stage	Amount	Investors
2024-01-10	Other	€2.5M	European Funds for a Modern Economy (FENG)	View deal →
2019-10-01	Other	€0	—	View deal →

same sector or country